OpenURL Connection Search

Select item for more details and to access through your institution.

A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 Macrophages.
Published in:
Cancers, 2023, v. 15, n. 18, p. 4635, doi. 10.3390/cancers15184635
By:
- Richert, Iseulys;
- Berchard, Paul;
- Abbes, Lhorra;
- Novikov, Alexey;
- Chettab, Kamel;
- Vandermoeten, Alexandra;
- Dumontet, Charles;
- Karanian, Marie;
- Kerzerho, Jerome;
- Caroff, Martine;
- Blay, Jean-Yves;
- Dutour, Aurélie
Publication type:
Article
A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical models.
Published in:
Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1066402
By:
- Chettab, Kamel;
- Fitzsimmons, Chantel;
- Novikov, Alexey;
- Denis, Morgane;
- Phelip, Capucine;
- Mathé, Doriane;
- Antoine Choffour, Pierre;
- Beaumel, Sabine;
- Fourmaux, Eric;
- Norca, Patrick;
- Kryza, David;
- Evesque, Anne;
- Jordheim, Lars Petter;
- Perrial, Emeline;
- Matera, Eva-Laure;
- Caroff, Martine;
- Kerzerho, Jerome;
- Dumontet, Charles
Publication type:
Article
High Therapeutic Efficacy of a New Survivin LSP-Cancer Vaccine Containing CD4<sup>+</sup> and CD8<sup>+</sup> T-Cell Epitopes.
Published in:
Frontiers in Oncology, 2018, p. N.PAG, doi. 10.3389/fonc.2018.00517
By:
- Onodi, Fanny;
- Maherzi-Mechalikh, Chahrazed;
- Mougel, Alice;
- Ben Hamouda, Nadine;
- Taboas, Charlotte;
- Gueugnon, Fabien;
- Tran, Thi;
- Nozach, Herve;
- Marcon, Elodie;
- Gey, Alain;
- Terme, Magali;
- Bouzidi, Ahmed;
- Maillere, Bernard;
- Kerzerho, Jérôme;
- Tartour, Eric;
- Tanchot, Corinne
Publication type:
Article
Diversity, Complexity, and Specificity of Bacterial Lipopolysaccharide (LPS) Structures Impacting Their Detection and Quantification †.
Published in:
International Journal of Molecular Sciences, 2024, v. 25, n. 7, p. 3927, doi. 10.3390/ijms25073927
By:
- Dardelle, Flavien;
- Phelip, Capucine;
- Darabi, Maryam;
- Kondakova, Tatiana;
- Warnet, Xavier;
- Combret, Edyta;
- Juranville, Eugenie;
- Novikov, Alexey;
- Kerzerho, Jerome;
- Caroff, Martine
Publication type:
Article

Found: 4

A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 Macrophages.

A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical models.

High Therapeutic Efficacy of a New Survivin LSP-Cancer Vaccine Containing CD4<sup>+</sup> and CD8<sup>+</sup> T-Cell Epitopes.

Diversity, Complexity, and Specificity of Bacterial Lipopolysaccharide (LPS) Structures Impacting Their Detection and Quantification †.